Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research4

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research4

FiltersClear all

Status

Active, not recruiting2
Completed2

Study type

Interventional4

Phase

Phase 2/34
Phase 325
Phase 219
Not applicable8
Phase 1/24
Phase 11

Investigator

Hani Lamie Ashamalla1
Manish A Shah1
Rajiv S. Magge1
Uqba Khan1

Department

Medicine2
Neurology1
Radiation Oncology1

Condition

Adenocarcinoma Of Esophagus1
Gliosarcoma1
Rectal Neoplasms1

Intervention type

Radiation4
Drug31
Biological7
Procedure7
Device3
Other2

Sponsor type

Other academic2
NIH2

Start date

Has results posted2

Phase 2/3×Radiation×Clear all

Showing 1–4 of 4 studiesSort:

Active, not recruitingInterventional · Phase 2/3NCT03604991 ↗
A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

FiltersClear all

Status

Active, not recruiting2
Completed2

Study type

Interventional4

Phase

Phase 2/34
Phase 325
Phase 219
Not applicable8
Phase 1/24
Phase 11

Investigator

Hani Lamie Ashamalla1
Manish A Shah1
Rajiv S. Magge1
Uqba Khan1

Department

Medicine2
Neurology1
Radiation Oncology1

Condition

Adenocarcinoma Of Esophagus1
Gliosarcoma1
Rectal Neoplasms1

Intervention type

Radiation4
Drug31
Biological7
Procedure7
Device3
Other2

Sponsor type

Other academic2
NIH2

Start date

Has results posted2

Phase 2/3×Radiation×Clear all

Showing 1–4 of 4 studiesSort:

Active, not recruitingInterventional · Phase 2/3NCT03604991 ↗
A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

Genetic

Manish A Shah

Intervention: Procedure: Biospecimen Collection · Drug: Carboplatin · Procedure: Computed Tomography · Biological: Ipilimumab · Biological: Nivolumab · Drug: Paclitaxel · Procedure: Positron Emission Tomography · Radiation: Radiation Therapy
Dates: May 2019 – Mar 2027 (est.)
Sponsor: ECOG-ACRIN Cancer Research Group

Clinical Stage II Esophageal Adenocarcinoma AJCC v8Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage III Esophageal Adenocarcinoma AJCC v8+5 more

Active, not recruitingInterventional · Phase 2/3NCT05610163 ↗

The Janus Rectal Cancer Trial: A Randomized Phase II/III Trial Testing the Efficacy of Triplet Versus Doublet Chemotherapy Regarding Clinical Complete Response and Disease-free Survival in Patients With Locally Advanced Rectal Cancer

Uqba KhanPI

Intervention: Drug: Capecitabine · Drug: 5-fluorouracil · Drug: Leucovorin calcium · Drug: Irinotecan · Drug: Oxaliplatin · Radiation: Long Course Chemoradiotherapy · Procedure: Computed Tomography · Procedure: Magnetic Resonance Imaging · Procedure: Sigmoidoscopy · Procedure: biopsy
Dates: Dec 2022 – Jul 2030 (est.)
Sponsor: Alliance for Clinical Trials in Oncology

Stage II Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8Locally Advanced Rectal Adenocarcinoma

CompletedInterventional · Phase 2/3NCT02635009 ↗

Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer

Hani Lamie AshamallaPI

Intervention: Radiation: Three-Dimensional Conformal Radiation Therapy · Radiation: Intensity-Modulated Radiation Therapy
Dates: Dec 2015 – May 2023· Results posted
Sponsor: NRG Oncology

Extensive Stage Small Cell Lung CarcinomaLimited Stage Small Cell Lung Carcinoma

CompletedInterventional · Phase 2/3NCT04396860 ↗

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma

Rajiv S. MaggePI

Intervention: Procedure: Contrast-enhanced Magnetic Resonance Imaging · Biological: Ipilimumab · Biological: Nivolumab · Device: NovoTTF-100A Device · Other: Quality-of-Life Assessment · Other: Questionnaire Administration · Radiation: Radiation Therapy · Drug: Temozolomide
Dates: Sep 2020 – Jan 2023· Results posted
Sponsor: NRG Oncology

GliosarcomaMGMT-Unmethylated Glioblastoma

Browse

Browse

A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

A Phase II/III Study of Peri-Operative Nivolumab and Ipilimumab in Patients With Locoregional Esophageal and Gastroesophageal Junction Adenocarcinoma

The Janus Rectal Cancer Trial: A Randomized Phase II/III Trial Testing the Efficacy of Triplet Versus Doublet Chemotherapy Regarding Clinical Complete Response and Disease-free Survival in Patients With Locally Advanced Rectal Cancer

Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma